Biomarkers in Triple-Negative Breast Cancer: State-of-the-Art and Future Perspectives

Triple-negative breast cancer (TNBC) is a heterogeneous group of tumors characterized by aggressive behavior, high risk of distant recurrence, and poor survival. Chemotherapy is still the main therapeutic approach for this subgroup of patients, therefore, progress in the treatment of TNBC remains an...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Int J Mol Sci
Autores principales: Cocco, Stefania, Piezzo, Michela, Calabrese, Alessandra, Cianniello, Daniela, Caputo, Roberta, Di Lauro, Vincenzo, Fusco, Giuseppina, di Gioia, Germira, Licenziato, Marina, de Laurentiis, Michelino
Formato: Artigo
Lenguaje:Inglês
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7369987/
https://ncbi.nlm.nih.gov/pubmed/32605126
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21134579
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares